Financhill
Back

Johnson & Johnson Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
29

JNJ
Johnson & Johnson

Last Price:
151.06
Seasonality Move:
2.59%
Sell
38

ITCI
Intra-Cellular Therapies

Last Price:
67.05
Seasonality Move:
-6.93%
Sell
29
Johnson & Johnson (JNJ) is a Sell

Is Johnson & Johnson a Buy, Sell or Hold?

  • The current Johnson & Johnson [JNJ] share price is $151.27. The Score for JNJ is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • JNJ is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $65.32. The Score for ITCI is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

JNJ Stock Price Chart

What is Johnson & Johnson's stock price today?

  • The Johnson & Johnson share price today is $151.27
    The current trend is relatively stagnant and JNJ is experiencing selling pressure, which indicates risk of future bearish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $65.32
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing slight buying pressure.

JNJ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.51 Buy
Relative Strength Index (14 RSI): 51.31 Buy
Chaikin Money Flow: -7402100 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (146.33 - 151.77) Buy
Bollinger Bands (100): (150.71 - 160.85) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.32 Sell
Relative Strength Index (14 RSI): 41.48 Sell
Chaikin Money Flow: 421582 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (66.45 - 74.29) Sell
Bollinger Bands (100): (65.99 - 72.19) Sell

JNJ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 151.9 Sell
20-day SMA: 149.72 Buy
50-day SMA: 152.16 Sell
200-day SMA: 156.83 Sell
8-day EMA: 151.94 Sell
20-day EMA: 150.79 Buy
50-day EMA: 151.97 Sell
200-day EMA: 156.36 Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 65.78 Sell
20-day SMA: 69.19 Sell
50-day SMA: 68.67 Sell
200-day SMA: 62.8 Buy
8-day EMA: 66.34 Sell
20-day EMA: 68 Sell
50-day EMA: 68.71 Sell
200-day EMA: 64.66 Buy

Johnson & Johnson Earnings Growth & JNJ Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.17 per share, an increase next quarter of $0.13 per share, an increase this year of $0.74 per share, and an increase next year of $0.31 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.45 per share, a decrease next quarter of $0.02 per share, an increase this year of $1.10 per share, and an increase next year of $1.43 per share.

Johnson & Johnson Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):